Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.
The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...
Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists in Australia.
Prostate cancer is the second most common cancer in men worldwide. The post Docs find new vulnerability that may mean better ...
B ATON ROUGE, La. (WAFB) - Baton Rouge General has upgraded its operating room with new robotic technology designed to help ...
Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...
An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...
Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of MASPIN and RASSF1A – genes that help block invasion, limit metastasis, and ...
A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...
Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling ...
A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive ...
News-Medical.Net on MSN
New drug combination could delay the progression of advanced prostate cancer
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results